Join Professor Chas Bountra, Professor of Translational Medicine and Professor Sir Charles Godfray as they discuss how the healthcare system has had to adapt due to the Covid-19 pandemic and what this means in the future.
Professor Chas Bountra
Lead Researcher, Oxford Martin Programme on Affordable Medicines
Chas Bountra is Pro Vice-Chancellor for Innovation at the University of Oxford; Professor of Translational Medicine in the Nuffield Department of Clinical Medicine; Lead Researcher on the Oxford Martin Programme on Affordable Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He is also a Visiting Professor in Neuroscience and Mental Health at Imperial College, London. Chas is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes.
He trained at King’s College London and the University of Edinburgh before taking up a post-doctoral fellowship and college lectureship in Physiology at Oxford. Prior to returning to Oxford, he worked for 19 years in the pharmaceutical industry, where he was involved in the development of candidate drugs for several diseases, including novel treatments for cancer chemotherapy and IBS. In 2018, he was awarded the “Order of the British Empire” in the New Years Honours list.
Professor Sir Charles Godfray
Director, Oxford Martin School
Professor Charles Godfray was appointed Director of the Oxford Martin School on 1 February 2018.
He is a population biologist with broad interests in the environmental sciences and has published in fundamental and applied areas of ecology, evolution and epidemiology.
He is interested in how the global food system will need to change and adapt to the challenges facing humanity in the 21st century, and in particular in the concept of sustainable intensification, and the relationship between food production, ecosystem services and biodiversity.
In 2017 he was knighted for services to scientific research and for scientific advice to government.
Keep in touch
If you found this page useful, sign up to our monthly digest of the latest news and eventsSubscribe